Literature DB >> 24680583

Obesity crisis in cancer care: gynecologic cancer prevention, treatment, and survivorship in obese women in the United States.

Susan Modesitt1, Joan Walker2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24680583     DOI： 10.1016/j.ygyno.2014.01.050

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  4 in total

1.  The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role.

Authors:  B Smith; R Neff; D E Cohn; F J Backes; A A Suarez; D G Mutch; C M Rush; C J Walker; P J Goodfellow
Journal:  Gynecol Oncol       Date:  2016-08-15       Impact factor: 5.482

2.  Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience.

Authors:  Siqing Fu; Naiyi Shi; Jennifer Wheler; Aung Naing; Filip Janku; Sarina Piha-Paul; Jing Gong; David Hong; Apostolia Tsimberidou; Ralph Zinner; Vivek Subbiah; Ming-Mo Hou; Pedro Ramirez; Lois Ramondetta; Karen Lu; Funda Meric-Bernstam
Journal:  Gynecol Oncol Res Pract       Date:  2015-11-14

3.  Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.

Authors:  Guangwei Wang; Xiaofei Liu; Dandan Wang; Meige Sun; Qing Yang
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

4.  The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.

Authors:  Jessica E Stine; Hui Guo; Xiugui Sheng; Xiaoyun Han; Monica N Schointuch; Timothy P Gilliam; Paola A Gehrig; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Oncotarget       Date:  2016-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.